World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
10446
World Ranking
3735
National Ranking
54

Carlo Heirman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carlo Heirman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 134 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carlo Heirman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carlo Heirman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carlo Heirman is affiliated with the Vrije Universiteit Brussel in Belgium and has contributed to research primarily within the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their research spans several subfields including Oncology, Immunology, Infectious Diseases, Molecular Biology, and Animal Science and Zoology.

The scientist's main topics of work focus on Immunotherapy and Immune Responses, SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, RNA Interference and Gene Delivery, and Single-cell and spatial transcriptomics.

Recent published papers include:

  • A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases, 2020, Cancer Immunology Immunotherapy
  • mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions, 2024, International Journal of Molecular Sciences
  • mRNA-LNP COVID-19 vaccine lipids induce low level complement activation and production of proinflammatory cytokines: Mechanisms, effects of complement inhibitors, and relevance to adverse reactions, 2024, bioRxiv (Cold Spring Harbor Laboratory)
  • Computational staining of CD3/CD20 positive lymphocytes in human tissues with experimental confirmation in a genetically engineered mouse model, 2024, Frontiers in Immunology
  • 1172 Computational Characterization of Immune Dysregulation in Oropharyngeal Squamous Cell Carcinoma, 2025, Laboratory Investigation

Frequent coauthors with whom Carlo Heirman collaborates include:

  • Tamás Bakos
  • Tamás Mészáros
  • Gergely Tibor Kozma
  • Petra Berényi
  • Réka Facskó

Their work has appeared in various scientific venues, notably:

  • Cancer Immunology Immunotherapy
  • International Journal of Molecular Sciences
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Laboratory Investigation

Best Publications

  • CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo.

    Roberto Maldonado-López;Thibaut De Smedt;Patrick Michel;Jacques Godfroid

  • Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation

    M. H. C. Bakkus;C. Heirman;I. Van Riet;B. Van Camp

  • Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma

    Sofie Wilgenhof;Jurgen Corthals;Carlo Heirman;Nicolas van Baren

  • CD83 expression on dendritic cells and T cells: correlation with effective immune responses.

    Cindy Aerts-Toegaert;Carlo Heirman;Sandra Tuyaerts;Jurgen Corthals

  • Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

    Aude Bonehill;Carlo Heirman;Sandra Tuyaerts;Annelies Michiels

  • Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients

    Aude Bonehill;An M.T. Van Nuffel;Jurgen Corthals;Sandra Tuyaerts

  • Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA

    Aude Bonehill;Sandra Tuyaerts;An M T Van Nuffel;Carlo Heirman

  • A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

    S. Wilgenhof;A.M.T. Van Nuffel;D. Benteyn;J. Corthals

  • Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

    Sandra Van Lint;Cleo Goyvaerts;Sarah Maenhout;Lode Goethals

  • Current approaches in dendritic cell generation and future implications for cancer immunotherapy.

    Sandra Tuyaerts;Joeri L. Aerts;Jurgen Corthals;Bart Neyns

  • Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo.

    R Maldonado-López;T De Smedt;B Pajak;C Heirman

  • Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.

    Karine Breckpot;Melissa Dullaers;Aude Bonehill;Sonja Van Meirvenne

  • A MAGE-A3 Peptide Presented by HLA-DP4 Is Recognized on Tumor Cells by CD4+ Cytolytic T Lymphocytes

    Erwin S Schultz;Bernard Lethé;Cesar L Cambiaso;Jacques Van Snick

  • Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma

    Sofie Wilgenhof;An M.T. Van Nuffel;Jurgen Corthals;Carlo Heirman

  • mRNA-based dendritic cell vaccines

    Daphné Benteyn;Carlo Heirman;Aude Bonehill;Kris Thielemans

  • Generation of large numbers of dendritic cells in a closed system using Cell Factories.

    Sandra Tuyaerts;Sofie M. Noppe;Jurgen Corthals;Karine Breckpot

  • Efficient genetic modification of murine dendritic cells by electroporation with mRNA.

    Sonja Van Meirvenne;Lieven Straetman;Carlo Heirman;Melissa Dullaers

  • The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy.

    Heleen Dewitte;Sandra Van Lint;Carlo Heirman;Kris Thielemans

  • Gain of 20q11.21 in human embryonic stem cells improves cell-survival by increased expression of Bcl-xL

    H.T. Nguyen;M. Geens;A. Mertzanidou;K. Jacobs

  • Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety

    Kevin Van der Jeught;Stefaan De Koker;Lukasz Bialkowski;Carlo Heirman

  • Characterization of CD8+ T-cell responses in the peripheral blood and skin injection sites of melanoma patients treated with mRNA electroporated autologous dendritic cells (TriMixDC-MEL).

    Daphné Benteyn;An M. T. Van Nuffel;Sofie Wilgenhof;Jurgen Corthals

  • Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.

    M Dullaers;S Van Meirvenne;C Heirman;L Straetman

Frequent Co-Authors

Kris Thielemans
Kris Thielemans Vrije Universiteit Brussel
Karine Breckpot
Karine Breckpot Vrije Universiteit Brussel
Pierre van der Bruggen
Pierre van der Bruggen Université Catholique de Louvain
Patrick De Baetselier
Patrick De Baetselier Vrije Universiteit Brussel
Muriel Moser
Muriel Moser Université Libre de Bruxelles
Karin Vanderkerken
Karin Vanderkerken Vrije Universiteit Brussel
Geert Raes
Geert Raes Vrije Universiteit Brussel
Oberdan Leo
Oberdan Leo Université Libre de Bruxelles
Gerold Schuler
Gerold Schuler University of Erlangen-Nuremberg
Viggo Van Tendeloo
Viggo Van Tendeloo University of Antwerp

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens various career doors within healthcare and research, but many students explore complementary paths in nursing to expand their expertise and job prospects. For those seeking a faster route into advanced nursing roles, an accelerated FNP program offers an efficient way to become a Family Nurse Practitioner with flexible online study options.

Individuals without a nursing background can also transition smoothly through specially designed online RN programs for non nurses. These programs provide foundational knowledge and prepare students for Registered Nurse licensure, making nursing careers more accessible.

For those seeking quicker entry into the nursing field, understanding the landscape of the easiest accelerated nursing programs to get into can be crucial. These programs balance rigorous training with streamlined admissions processes, allowing students to advance rapidly.

Similarly, Licensed Practical Nurse roles remain in demand, and exploring the best easiest LPN programs to get into offers a practical pathway into healthcare without prolonged education commitments. Each of these options can enhance an immunology graduate’s career trajectory, providing diversified opportunities in health sciences.

Best Scientists Citing Carlo Heirman

Trending Scientists

Recently Published Articles